Tag Archives: King Pharmaceuticals

Pfizer to Acquire King Pharmaceuticals

By Jennifer Ringler | Published: October 12, 2010
The merger, announced on Tuesday, will cost Pfizer $3.6 billion. Pfizer and King Pharmaceuticals announced on Tuesday they have entered into a definitive friendly merger agreement. Under the terms, Pfizer will acquire King, a diversified specialty pharmaceutical company based in Tennessee, for $3.6 billion in cash, or $14.25 per share. The company emphasized the deal is not [...]
Posted in Deals | Also tagged | Leave a comment

PhRMA and the New Physician Marketing

By Brittany Agro | Published: November 7, 2008
I was amazed at the more than 700 women attending the 2008 Women’s Healthcare Business Association (HBA) national conference today. As a first timer at the event (distinguished by the bright orange sticker on my name badge), it was easy to engage in conversations—even for those weary of the press. And for marketers, there was [...]
Posted in Events | Also tagged , , , , , , | Leave a comment

King Ups Alpharma Offer

By George Koroneos | Published: September 11, 2008
King Pharmaceuticals sweetened its offer to purchase Alpharma this morning. The drug firm boosted the bid price to $37 per share or $1.6 billion from the initial of $33 a share it presented in early August. If Alpharma refuses, King is prepared to get down and dirty. In a pointed letter to Alpharma’s board, King President [...]
Posted in Deals | Also tagged , , , , , | Leave a comment